Sulaiman Al-Hashmi

Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase

Sulaiman Al-Hashmi, P. J. Boels, Fahad Zadjali et al. · PLoS ONE · 2012 · 38 citations · Full text

Medicine, Pharmacology, Cell Therapy +11

Early-phase GVHD gene expression profile in target versus non-target tissues: kidney, a possible target?

Behnam Sadeghi, Heevy Al-Chaqmaqchi, Sulaiman Al-Hashmi et al. · Bone Marrow Transplantation · 2012 · 27 citations

Life Sciences, Immunology, Molecular Biology +10

Accuracy of Platelet Counting by Optical and Impedance Methods in Patients with Thrombocytopaenia and Microcytosis

Mohamed‐Rachid Boulassel, Raya Al-Farsi, Sulaiman Al-Hashmi et al. · Sultan Qaboos University medical journal · 2015 · 19 citations · Full text

Medicine, Hematology, Biomedical Optics +13

Dynamics of early histopathological changes in GVHD after busulphan/cyclophosphamide conditioning regimen.

Sulaiman Al-Hashmi, Zuzana Hassan, Behnam Sadeghi et al. · PubMed · 2011 · 15 citations · Full text

Medicine, Hematology, Immunology +15

The Role of Programmed Cell Death Ligand-1 (PD-L1/CD274) in the Development of Graft versus Host Disease

Heevy Al-Chaqmaqchi, Behnam Sadeghi, Manuchehr Abedi‐Valugerdi et al. · PLoS ONE · 2013 · 14 citations · Full text

Life Sciences, Immunology, Oncology +14